Guizhou Yibai Pharmaceutical Co., Ltd. (600594)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
3. 83
+0.05
+1.3228%
¥
2.81B Market Cap
- P/E Ratio
0.26% Div Yield
52.8M Volume
- Eps
¥ 3.78
Previous Close Want to track 600594 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600594 closed today higher at ¥3.83, an increase of 1.3228% from yesterday's close, completing a monthly increase of 28.9562% or ¥0.86. Over the past 12 months, 600594 stock lost -3.7688%.
600594 is not paying dividends to its shareholders.
The last earnings report, released on Jun 04, 2024, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0233%, based on the last three reports.
Guizhou Yibai Pharmaceutical Co., Ltd. has completed 7 stock splits, with the recent split occurring on Jul 16, 2015.
The company's stock is traded on one exchange.
600594 Chart
People also search for
Guizhou Yibai Pharmaceutical Co., Ltd. (600594) FAQ
What is the stock price today?
The current price is ¥3.83.
On which exchange is it traded?
Guizhou Yibai Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600594.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.26%.
What is its market cap?
As of today, the market cap is 2.81B.
Has Guizhou Yibai Pharmaceutical Co., Ltd. ever had a stock split?
Guizhou Yibai Pharmaceutical Co., Ltd. had 7 splits and the recent split was on Jul 16, 2015.
Guizhou Yibai Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Ya Qi Dou CEO | SSE Exchange | CNE000001H03 ISIN |
| CN Country | 5,509 Employees | 8 Jun 2021 Last Dividend | 15 Oct 2010 Last Split | 8 Mar 2004 IPO Date |
Overview
Guizhou Yibai Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical sector of China, boasting a rich history of research, development, production, and sales of pharmaceutical products since its inception in 1995. Positioned in Guiyang, China, the company has carved out a robust presence in the highly competitive pharmaceutical landscape through its commitment to innovation and the delivery of effective healthcare solutions.
Products and Services
The company delivers a vast array of pharmaceutical products across multiple therapeutic categories, emphasizing quality and patient safety. Below is a detailed list of their offerings:
- Capsules, Tablets, Granules, Syrups: These oral pharmaceutical forms are designed to address a wide range of conditions, offering ease of administration and effective disease management.
- Small-Volume Injections, Freeze-Dried Powder Injections: Utilized primarily for their rapid action and specificity, these products cater to acute care needs and chronic disease management, including tumor treatments.
- Pills, Oral Solutions: These traditional and widely accepted pharmaceutical forms are crafted to ensure patient compliance, ease of use, and effectiveness in treating various ailments.
- Tumor System: Dedicated oncology products targeting various aspects of cancer care, from chemotherapy to supportive care, reflecting the company’s commitment to battling this chronic disease.
- Cerebrovascular and Respiratory System: Products developed to address diseases affecting the cerebrovascular and respiratory systems, showcasing the company's focus on cardiopulmonary health.
- Rheumatism, Digestive System: A range of treatments targeting rheumatic conditions and digestive system disorders, emphasizing the company's attention to chronic diseases that affect a large portion of the population.
- Pediatric, Gynecological: Specialized products that cater to the specific needs of pediatric and gynecological patients, underlining the company's dedication to comprehensive care across all age groups and genders.
- Anti-Infection, Anti-Inflammatory, Analgesic: These therapeutic categories include products designed to combat infections, manage inflammation, and relieve pain, addressing some of the most common and pressing health concerns.
Contact Information
Address: No. 220-1, Baiyun Avenue, Guiyang, China, 550008
Phone: 86 85 1847 05590
Website: https://www.gzcci.com
